L A Guay - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

AIDS (London, England)|October 16, 2001

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.

AIDS (London, England)|April 10, 1999

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)P Musoke, L A Guay, D Bagenda, et al.

Lancet (London, England)|September 15, 1999

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialL A Guay, P Musoke, T Fleming, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

AIDS (London, England)|October 16, 2001

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.

AIDS (London, England)|April 10, 1999

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)P Musoke, L A Guay, D Bagenda, et al.

Lancet (London, England)|September 15, 1999

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialL A Guay, P Musoke, T Fleming, et al.

Pageof 2